Member Login
  1. Stocks
    2. /
  2. Genus plc (LSE: GNS)
    3. /

LSE:GNS (Genus plc)

About GNS

Genus applies science to animal breeding. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors. It is a provider of bovine genetics and reproduction services, marketing in more than 70 countries.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

  • Should you invest £1,000 in Compass Group Plc right now?

    When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

    Mark and his analyst team just revealed what they believe are the 6 best stocks for investors to buy right now... and Compass Group Plc wasn’t on the list. Right now, they think there are 6 stocks that are better buys!

    See the 6 stocks

    • Genus plc (LSE: GNS) Latest News

    Investing Articles

    Why I’d buy this small-cap over Genus plc despite today’s positive results

    | Peter Stephens

    This smaller company has better growth prospects than Genus plc (LON: GNS).

    Read more »

    Investing Articles

    Are these two hot biotechnology shares to buy today?

    | Alan Oscroft

    Biotechnology is big business, but can you spot tomorrow's winners?

    Read more »

    Investing Articles

    3 Healthcare Stocks With More Downside Than Upside? Shire PLC, Alliance Pharma plc And Genus plc

    | Peter Stephens

    Should you buy or sell these 3 healthcare stocks? Shire PLC (LON: SHP), Alliance Pharma plc (LON: APH) and Genus…

    Read more »

    Investing Articles

    AstraZeneca plc, Smith & Nephew plc And Genus plc: Buy, Sell Or Hold?

    | Peter Stephens

    What will 2016 and beyond have in store for AstraZeneca plc (LON: AZN), Smith & Nephew plc (LON: SN) and…

    Read more »

    Investing Articles

    GlaxoSmithKline plc, Genus plc And Alliance Pharma plc: 3 Of The Best Health Care Stocks?

    | Peter Stephens

    Could these 3 health care companies really be the pick of their sector? GlaxoSmithKline plc (LON: GSK), Genus plc (LON:…

    Read more »

    Investing Articles

    Does Sepura Plc Offer More Value Than Genus plc & SDL plc After A 24% Rally?

    | Alessandro Pasetti

    Sepura Plc (LON:SEPU), Genus plc (LON:GNS) and SDL plc (LON:SDL) are under the spotlight.

    Read more »

    Investing Articles

    Is AstraZeneca plc A Better Buy Than BTG plc, Dechra Pharmaceuticals plc And Genus plc?

    | Peter Stephens

    How does AstraZeneca plc (LON: AZN) stack up against three pharmaceutical peers: BTG plc (LON: BTG), Dechra Pharmaceuticals plc (LON:…

    Read more »

    Investing Articles

    Are Genus plc And Dechra Pharmaceuticals plc Better Buys Than GlaxoSmithKline plc?

    | Peter Stephens

    Which of these 3 pharmaceutical companies should you add to your portfolio? Genus plc (LON: GNS), Dechra Pharmaceuticals plc (LON:…

    Read more »

    Investing Articles

    Why Gulf Keystone Petroleum Limited, Genus plc And Johnson Service Group plc Should Lag The FTSE 100 Today

    | Alan Oscroft

    Gulf Keystone Petroleum Limited (LON: GKP), Genus plc (LON: GNS) and Johnson Service Group plc (LON: JSG) are all slipping.

    Read more »